Objectives: Benign and malignant intraosseous schwannomas are rare, and primarily documented in case reports. This study aims to elucidate the differences in clinical features and imaging manifestations between these tumors. This will help clinicians identify malignant lesions at an early stage, reliable guide treatment decisions, and accurately predict outcomes.
Methods: Eighteen patients who underwent surgery and got pathological examinations in our hospital from 2012 to 2023 were retrospectively reviewed. Among them, 14 cases were found benign with 4 malignant. In the benign group, patients underwent curettage followed by bone grafting, whereas the malignant group was treated with extensive resection or amputation. Patients’ demographics and radiographic features, including gender, age at diagnosis, symptom duration, tumor location, tumor margin, and the ratio of sclerotic margins were documented and compared between these tumors. All imaging was reviewed by two fellowship-trained musculoskeletal radiologists, who also quantified the sclerotic margin ratio. The intraclass correlation coefficient was used to determine inter-observer agreement. The Mann–Whitney U test was applied for continuous clinical variables, and the chi-square test or Fisher’s exact test for categorical variables.
Results: In our series, the mean age of these patients was 43.1 ± 14.0 years, six patients were male and 12 were female. Pain was the predominant preoperative symptom. The average duration from symptom onset to initial physician visit was 28.5 ± 25.3 months for benign schwannomas and 8.3 ± 4.3 months for malignant schwannomas (p = 0.012). On plain radiographs, 13 (13/14) of benign schwannomas exhibited well-defined margins of bone destruction, compared to 1 (1/4) of malignant schwannomas (p = 0.019). Furthermore, benign schwannomas had a significantly higher sclerotic margin ratio (75.5%) than malignant ones (16.7%) (p = 0.001). No statistically significant difference was found between the two groups in terms of cortical bone destruction (p = 1.0). On MRI, both tumors demonstrated intermediate to slightly hypointense signal intensity on T1-weighted images and heterogeneous high signal intensities on T2-weighted images.
Conclusions: Despite their rarity, benign and malignant intraosseous schwannomas should be considered in the differential diagnosis for patients presenting with painful and radiographically lytic bone lesions, especially in the mandible, sacrum, and vertebrae. The ratio of sclerotic margins, which we proposed for the first time, in combination with symptom duration and the clarity of tumor margins, provide valuable diagnostic clues for distinguishing the malignancy of the tumors.
| [1] |
D. N. Louis, A. Perry, P. Wesseling, et al., “The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary,” Neuro-Oncology 23, no. 8 (2021): 1231–1251.
|
| [2] |
C. M. Ida, B. W. Scheithauer, O. Yapicier, et al., “Primary Schwannoma of the Bone: A Clinicopathologic and Radiologic Study of 17 Cases,” American Journal of Surgical Pathology 35, no. 7 (2011): 989–997.
|
| [3] |
S. M. de la Monte, H. D. Dorfman, R. Chandra, and M. Malawer, “Intraosseous Schwannoma: Histologic Features, Ultrastructure, and Review of the Literature,” Human Pathology 15, no. 6 (1984): 551–558.
|
| [4] |
K. J. Fawcett and D. C. Dahlin, “Neurilemmoma of Bone,” American Journal of Clinical Pathology 47, no. 6 (1967): 759–766.
|
| [5] |
K. Y. Oh and S. D. Hong, “Malignant Peripheral Nerve Sheath Tumor of the Maxilla: Case Report and Review of the Literature With Emphasis on Its Poor Prognosis,” Oral Oncology 135 (2022): 106211.
|
| [6] |
X. Peng, L. Chen, H. Du, Y. Lai, F. Li, and X. Zou, “Malignant Transformation of Benign Intraosseous Schwannoma in the Cervical Spine: A Case Report With an Immunohistochemical Study,” International Surgery 96, no. 4 (2011): 337–344.
|
| [7] |
A. Lesic, M. Bumbasirevic, H. D. Atkinson, R. Maksimovic, J. Sopta, and M. Atanackovic, “Malignant Intraosseous Peripheral Nerve Sheath Tumour of the Proximal Femur: A Case Report,” Journal of Orthopaedic Surgery (Hong Kong) 14, no. 1 (2006): 84–89.
|
| [8] |
K. Gnanalingham, S. Bhattacharjee, and K. O’Neill, “Intraosseous Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Thoracic Spine: A Rare Cause of Spinal Cord Compression,” Spine (Phila Pa 1976) 29, no. 18 (2004): E402–E405.
|
| [9] |
M. J. Bullock, Y. C. Bedard, R. S. Bell, and R. Kandel, “Intraosseous Malignant Peripheral Nerve Sheath Tumor. Report of a Case and Review of the Literature,” Archives of Pathology & Laboratory Medicine 119, no. 4 (1995): 367–370.
|
| [10] |
M. Gambarotti, A. Righi, M. Sbaraglia, et al., “Primary Malignant Peripheral Nerve Sheath Tumors of Bone: A Clinicopathologic Reappraisal of 8 Cases,” Human Pathology 122 (2022): 92–102.
|
| [11] |
R. J. K Khan, J. Asgher, M. T. Sohail, and A. S. Chughtai, “Primary Intraosseous Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the Literature,” Pathology 30, no. 3 (1998): 237–241.
|
| [12] |
T. K. L Kendi, A. Erakar, H. Y. Yildiz, Y. Saglik, and S. Erekul, “Intraosseous Malignant Peripheral Nerve Sheath Tumor With Local Recurrence, Lung Metastases and Death,” Skeletal Radiology 33, no. 4 (2004): 223–225.
|
| [13] |
A. Afshar and F. Afaghi, “Intraosseous Schwannoma of the Second Metacarpal: Case Report,” Journal of Hand Surgery 35, no. 5 (2010): 776–779.
|
| [14] |
X. J. Wang, K. Hartley, G. E. Holt, O. Fadare, and J. M. Cates, “Intracortical Schwannoma of the Femur,” Skeletal Radiology 43, no. 5 (2014): 687–691.
|
| [15] |
N. Sun, U. Z. Khan, L. Zeng, et al., “Successful Management of a Rare Radius Schwannoma Mimicking Malignant Bone Tumors: A Case Report and Literature Review,” Frontiers in Surgery 10 (2023): 1108942.
|
| [16] |
S. Summers, J. Jose, C. M. Barrera, et al., “Intraosseous Schwannomas Involving the Sacrum: Characteristic Imaging Findings and Review of the Literature,” Neuroradiology Journal 31, no. 5 (2018): 531–540.
|
| [17] |
F. Shomal Zadeh, A. Azhideh, J. G. Mantilla, et al., “Imaging Features of Intraosseous Schwannoma: A Case Series and Review of the Literature,” Diagnostics 13, no. 9 (2023): 1610.
|
| [18] |
S. Li, Z. Wang, Z. Li, S. Xie, X. Shan, and Z. Cai, “Intraosseous Schwannoma of the Mandible: New Case Series, Literature Update, and Proposal of a Classification,” International Journal of Oral and Maxillofacial Surgery 53, no. 3 (2024): 205–211.
|
| [19] |
S. Kujala, M. Kallioinen, M. Forsman, and J. Ryhänen, “Intraosseous Schwannoma of the Middle Phalanx,” Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 40, no. 5 (2009): 318–320.
|
| [20] |
J. Giné, J. Calmet, J. J. Sirvent, and S. Domènech, “Intraosseous Neurilemmoma of the Radius: A Case Report,” Journal of Hand Surgery 25, no. 2 (2000): 365–369.
|
| [21] |
M. Kito, Y. Yoshimura, I. Ki, K. Aoki, T. Momose, and H. Kato, “Intraosseous Neurilemmoma of the Proximal Ulna,” International Journal of Surgery Case Reports 5, no. 12 (2014): 914–918.
|
| [22] |
M. Hoshi, J. Takada, N. Oebisu, and H. Nakamura, “Intraosseous Schwannoma of the Proximal Femur,” Asia-Pacific Journal of Clinical Oncology 8, no. 3 (2012): e29–e33.
|
| [23] |
V. Gurkan, C. Sonmez, A. Aralasmak, F. Yildiz, and O. Erdogan, “An Unusual Localization of Intraosseous Schwannoma: The Hamate Bone,” Clinics and Practice 7, no. 1 (2017): 920.
|
| [24] |
Y. Q. Wang, J. X. Hu, S. M. Yang, et al., “Intraosseous Schwannoma of the Mobile Spine: A Report of Twenty Cases,” European Spine Journal 27, no. 12 (2018): 3092–3104.
|
| [25] |
S. Muthusamy, S. A. Conway, J. D. Pitcher, and H. T. Temple, “Primary Intraosseous Malignant Peripheral Nerve Sheath Tumor of the Medial Cuneiform: A Case Report and Review of the Literature,” Journal of Foot and Ankle Surgery 56, no. 1 (2017): 129–134.
|
| [26] |
J. S. Yun, M. H. Lee, S. M. Lee, et al., “Peripheral Nerve Sheath Tumor: Differentiation of Malignant From Benign Tumors With Conventional and Diffusion-Weighted MRI,” European Radiology 31, no. 3 (2021): 1548–1557.
|
| [27] |
I. Ristow, M. G. Kaul, M. Stark, et al., “Discrimination of Benign, Atypical, and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Using Diffusion-Weighted MRI,” Neuro-Oncology Advances 6, no. 1 (2024): vdae021.
|
| [28] |
H. Koike, Y. Nishida, S. Ito, et al., “Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign From Malignant Peripheral Nerve Sheath Tumors,” World Neurosurgery 157 (2022): e207–e214.
|
| [29] |
F. Habibzadeh, P. Habibzadeh, and M. Yadollahie, “On Determining the Most Appropriate Test Cut-Off Value: The Case of Tests With Continuous Results,” Biochemia Medica 26, no. 3 (2016): 297–307.
|
RIGHTS & PERMISSIONS
2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
